Dermitage Skincare Study Results
According to Robertson, anti-aging skincare products work best when they’re used consistently over eight to twelve weeks, allowing for the treatment to work through the layers of the skin, to treat wrinkles and reduce age spots over time. “But, it’s tough to wait that long to see results”, said Robertson, “we were very excited to learn that DermitĂ ge provides these measurable benefits within the first three weeks of use.”
Some participants saw results in as little as one day. Forty percent of participants reported smoother skin and 30% reported brighter, more luminous skin after just one day of use.The Dermitage anti-aging system features a proprietary ingredient complex that combines Instant Lifting Spheres with Glucosamine. Instant Lifting Spheres work by settling beneath wrinkles and capturing the moisture that would normally escape from your skin. This moisture causes the spheres to gently swell from underneath, lifting out fine lines and wrinkles within minutes. Glucosamine Complex, a powerful marine-based skin renewal booster, increases cellular turnover while dramatically improving hydration and stimulating natural collagen production. Both ingredients are encapsulated in a patented delivery technology that allows deeper penetration and sustained release.
“We’re very pleased to announce that the Dermitage Anti-Aging System provides significant skin improvement in just three weeks”, said Michelle Robertson, Director of Skincare for Dermitage. The study provided 270 women, aged 21-70, with the DermitĂ ge Anti-Aging System for use at home during a three week period.
The most significant findings of the three-week use study were:
82% of participants reported fewer fine lines and wrinkles
83% reported firmer, brighter skin
90% reported smoother skin
The average user saw skin luminosity, brightness and overall skin tone improve by 35% and skin hydration increase by 50%.
Related Posts:
If you enjoyed this post, please consider leaving a comment, subscribe to the feed and get future articles delivered to your feed reader or follow us on Twitter.
Comments
No comments yet.
Leave a comment